P3591Impact of changing European guideline oral anticoagulation treatment thresholds on stroke and mortality in patients with atrial fibrillation

Laurent Fauchier; Arnaud Bisson; Clémentine André; Nicolas Clémenty; Alexandre Bodin; Bernard Pierre; Denis Angoulvant; D Babuty; Professor Gregory Lip

doi:10.1093/eurheartj/ehx504.p3591

Back

P3591Impact of changing European guideline oral anticoagulation treatment thresholds on stroke and mortality in patients with atrial fibrillation

Article 2017 en

Related publications

Article2021

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation

P. H. Kevin Chang, Wei‐Ting Wang, Yi‐Wen Tsai, Hao‐Min Cheng, Wei-Lun Wu, Hui‐Chin Chang, Chen‐Huan Chen, Shih‐Hwa Chiou, Professor Gregory Lip, Chern‐En Chiang

Article2018

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey

Deirdre A. Lane, Juliane Meyerhoff, Ute Rohner, Professor Gregory Lip

Article2016

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

Raphaël Philippart, Anne Brunet-Bernard, Nicolas Clémenty, Thierry Bourguignon, Alain Mirza, Denis Angoulvant, Dominique Babuty, Professor Gregory Lip, Laurent Fauchier

Article2017

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor, Mariano Valdés, Vicente Vicente, Professor Gregory Lip, Francisco Marı́n

Article2017

TREATMENT AND OUTCOMES OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ACCORDING TO GUIDELINE-DEFINED ANTICOAGULATION THRESHOLDS: RESULTS FROM THE GARFIELD-AF REGISTRY

A. John Camm, Gabriele Accetta, Giancarlo Agnelli, Jean‐Pierre Bassand, Samuel Z. Goldhaber, Gloria Kayani, Frank Misselwitz, Seil Oh, Pekka Raatikainen, Alexander G.G. Turpie, Martin van Eickels, Ajay K. Kakkar

P3591Impact of changing European guideline oral anticoagulation treatment thresholds on stroke and mortality in patients with atrial fibrillation

Discussion(0)

Related publications

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

TREATMENT AND OUTCOMES OF PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ACCORDING TO GUIDELINE-DEFINED ANTICOAGULATION THRESHOLDS: RESULTS FROM THE GARFIELD-AF REGISTRY